# Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure

Study · id `cardio:ct-nct01920048` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01920048](<https://clinicaltrials.gov/study/NCT01920048>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01920048

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 700 participants.

## Technical summary

Registry record NCT01920048. Randomized; no masking; primary purpose treatment. Start 2013-08-28 (actual); primary completion 2020-03-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 700 participants (enrolled count; ClinicalTrials.gov record NCT01920048, source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)
- Started: 2013-08-28 (actual) (ClinicalTrials.gov record NCT01920048, source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)
- Primary completion: 2020-03-19 (actual) (ClinicalTrials.gov record NCT01920048, source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)
- Completion: 2022-03-31 (actual) (ClinicalTrials.gov record NCT01920048, source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT01920048, source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01920048-2022-05-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure
- Acronym: REVIVED-BCIS2
- Condition: Ischemic Cardiomyopathy
- Intervention (Procedure): Percutaneous Coronary Intervention
- Intervention (Drug): Drug Therapy for Heart Failure
- Intervention (Device): Device Therapy for Heart Failure
- Lead sponsor: King's College London
- Lead sponsor class: OTHER
- Collaborator: National Institute for Health Research, United Kingdom
- Collaborator class: OTHER\_GOV
- Collaborator: London School of Hygiene and Tropical Medicine
- Collaborator class: OTHER
- Collaborator: University of York
- Collaborator class: OTHER
- Collaborator: Guy's and St Thomas' NHS Foundation Trust
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: King's College London (`cardio:org-king-s-college-london`)
- Registry lists this organization as a collaborator: National Institute for Health Research, United Kingdom (`cardio:org-national-institute-for-health-research-united-kingdom`)
- Registry lists this organization as a collaborator: London School of Hygiene and Tropical Medicine (`cardio:org-london-school-of-hygiene-and-tropical-medicine`)
- Registry lists this organization as a collaborator: Guy's and St Thomas' NHS Foundation Trust (`cardio:org-guy-s-and-st-thomas-nhs-foundation-trust`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction (`cardio:pubmed-36027563`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial (`cardio:pubmed-37555345`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial (`cardio:pubmed-37929587`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy (`cardio:pubmed-38759904`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2 (`cardio:pubmed-38727649`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of baseline risk of death or hospitalization on effectiveness of revascularization in patients with ischaemic left ventricular dysfunction-a prespecified analysis of REVIVED-BCIS2 (`cardio:pubmed-40972554`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f07538105b8140f9143e1aa22d6e4d38ed2a2b618c00bc488ebb938175d1570a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
